Background: Melasma has a major impact on quality of life. MELASQoL is the only validated specific psychometric instrument to evaluate melasma QoL. oBjective: To develop and validate a multidimensional questionnaire for evaluating quality of life related to facial melasma. Methods: Cross-sectional study performed in 2 institutions (public and private) from Brazil. Two focus groups were carried out: 5 board-certified dermatologists and 10 melasma patients, indicating the dimensions and significant units of melasma QoL. The preliminary questionnaire with 49 itens was applied to 154 facial melasma patients. Item reduction was performed by Rasch analysis. Parallel evaluations of clinical (MASI), demographic, and QoL aspects (MELASQoL, DLQI) were performed. The dimensional structure was assessed by confirmatory factor analysis. Temporal stability was tested in a subgroup of 42 individuals within 7-14 days. results: The mean (SD) age of the 154 interviewed subjects was 39±8 years, and 87% were females. The median (p25-p75) DLQI and MELASQoL were: 2 (1-6) and 30 (17-44). HRQ-Melasma consisted of 19 items distributed in 4 dimensions: Physical/ Appearance, Social/Professional, Psychological, and Treatment. Cronbach's alpha for HRQ-Melasma was 0.96, and >0.74 for each dimension. There was high correlation between HRQ-Melasma and DLQI and MELASQoL (rho=0.80 and 0.83), but modest with MASI (rho=0.35). Dimensional structure of HRQ-Melasma was stated by confirmatory factor analysis coefficients. Test-retest analysis disclosed an intraclass correlation coefficient of 0.91 (p<0.01). study liMitations: Single-center study. conclusions: A specific instrument to evaluate QoL in melasma with multidimensional characteristics was developed and validated, with appropriate psychometric performance.
INTRODUCTION
Melasma is a common chronic hypermelanosis characterized by symmetrical hyperchromic macules on photo-exposed skin, mainly the face. It occurs most frequently in childbearing-age women. Despite treatment, lesions tend to recur. 1, 2 Dermatoses can influence self-image and have the potential to trigger processes which affect self-esteem, promoting feelings of anxiety, unhappiness, or even depressive disorders. Although asymptomatic, melasma affects visible areas and has an important impact on quality of life (QoL). [3] [4] [5] [6] The World Health Organization defines QoL as "individuals' perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards, and concerns". 7 Meanwhile, health-related quality of life, which is a broad general concept that can vary significantly among different populations and cultures, is being used as an outcome in clinical trials. 8 In 2003, the only specific instrument for evaluating melasma-related QoL was developed and validated: MELASQoL (Melasma Quality of Life Scale). The authors based it on SKINDEX-16 (7 Development and validation of a multidimensional questionnaire for evaluating quality of life in melasma (HRQ-melasma)
items) and a questionnaire on changes in skin color (3 items). 9 MELASQoL has been adapted and validated in different countries and used in various clinical trials. [10] [11] [12] [13] [14] [15] [16] [17] [18] Criticisms have been raised about the construction process and application of MELASQoL, including: difficulties in the semantic interpretation of items, having been validated only in women, no prior qualitative analysis of perception about the disease, low representation of the dimension of feelings and selfesteem, lack of psychometric studies in relation to scalability, and temporal stability. 19 These arguments indicate a need for developing new tools for evaluating QoL in melasma.
In this study we developed and validated a multidimensional instrument for evaluating QoL related to facial melasma in Brazil.
METHODS
This was a cross-sectional study performed at the School Participation in the study included: 1) board-certified dermatologists and 2) patients with facial melasma over 18 years of age and from both genders, without other facial dyschromia.
Focus Groups
The first focus group consisted of 5board-certified dermatologists responding to the guided question: "In which aspects does melasma upset the life of patients?" This group oriented the main dimensions affected by melasma.
The second focus group consisted of 10 melasma patients recruited from the 2 institutions, responding to the guided question:
"In your opinion, how does melasma affect your life?" within each dimension identified by the first focus group. These patients were selected on the basis of suitable intellectual and educational level for the discussion. This group provided information for item elaboration.
Both focus groups followed methodological steps: building a script of issues, formulation of representativeness criteria, and data collection on different individual perceptions.
The answers were recorded and analyzed according to Bardin content analysis, based on a preliminary definition of the dimensions affected by melasma (first focus groups).
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Content Analysis
The narratives were analyzed by following the steps of content analysis, in 3 phases. Pre-analysis: the organizational stage of the material and systematization of ideas; exploration of material: consisted of the data categorization operation in the transformation of raw data in order to achieve a core understanding of the text. This stage included cropping (selection of units of meaning) and data categorization. The last step was processing and interpretation of results.
The dermatologists' narratives were transcribed, and the instrument's dimensions emerged from these.
Patient narratives were transcribed and summarized to identify significant units, resulting in the preliminary composition of items for each dimension of the instrument.
Semantic Adaptation and Content Validation
The preliminary questionnaire, defined with 49 items in 7 dimensions, was analyzed by 5 specialists for item suitability (face validation) and semantics, and was also submitted to 10 patients for semantic and cultural adjustments to the items.
Data Collection
The preliminary questionnaire was applied to 154 facial melasma patients. Parallel evaluations were performed of clinical aspects (MASI -Melasma Area Severity Index), visual analogue scale for self-perception of inconvenience with 5 levels (developed for this study), and demographic and quality of life aspects: MELASQoL-PB, DLQI-BRA. 9, 11, [21] [22] [23] A convenience sample was used, with patients included after giving informed consent to participate in the study.
Item Reduction
The performance of items within each dimension was analyzed according to Item Response theory: polytomous Rasch model for ordinal data (Samejima graded model).
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Questionnaire reduction was accomplished according to the contribution of information from each item within each dimension, with low-informativity items being excluded.
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Questionnaire Validation
Validation of the reduced questionnaire (HRQ-Melasma) was performed by evaluating the internal consistency and correlation with other quality of life instruments (concurrent validity).
Dimensional Evaluation
The dimensional structure of HRQ-Melasma was tested by confirmatory factor analysis. Adjustment of the multidimensional model was performed through the following tests: chi-square by degrees of freedom ratio (CMIN/DF), adjusted goodness-of-fit index (AGFI), comparative fit index (CFI), and root mean square error of approximation (RMSEA).
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Temporal Stability Test-retest stability of the final construct (HRQ-Melasma)
and MELASQoL-BP in a subgroup of 42 individuals was analyzed 7-14 days after the interviews. HRQ-QoL was completed by the subjects in less than 10 minutes.
Statistical Analysis
DISCUSSION
A new multidimensional structured questionnaire was developed and validated to evaluate QoL in patients with facial melasma, following the classical steps of psychometry. 37 The focus groups revealed different aspects of daily life in which the condition affects QoL.
The study sample was representative not only of Brazilian melasma patients as a whole (mainly childbearing-age women 38, 39 ), but also for development of the psychometric instrument, since it evaluated individuals with heterogeneous socioeconomic levels Likewise, test-retest stability was high, altogether lowing its use in clinical practice and research.
The study's main limitation was its single-center design.
The psychometric and structural properties of HRQ-Melasma should be explored in other cultural and linguistic settings with analytical tools adjusted to the measures' statistical characteristics in order to identify the construct's strengths and weaknesses for investigating quality of life in melasma.
CONCLUSIONS
We developed a specific multidimensional instrument to assess QoL in melasma, with suitable psychometric performance. q
